FDA Grants Empagliflozin Broad Heart Failure Indication
The landmark approval for the SGLT-2 inhibitor will open access to treatment for the ~ 3 million adults with heart failure with preserved ejection fraction.
Regular Use of Acetaminophen May Significantly Increase Hypertension and CV Risk
In the PATH-BP study, use of acetaminophen 4g/day increased BP among patients with hypertension by nearly 5 mm Hg within 2 weeks of beginning the regimen.
FDA Grants Clearance to First Smartphone App for Programming Insulin Dosing
t:slim X2 insulin pump users can now program or cancel bolus dosing with the secure t:connect mobile app already on their phones, says Tandem Diabetes Care.
Racial/Ethnic Bias Found in Asthma Clinical Trials Used to Update NHLBI Guideline
In the majority of studies that reported racial/ethnic data, White participants were highly overrepresented and Black/Hispanic/all Other underrepresented.
In Patients with T2D and ASCVD, Prescriptions for Evidence-based Therapies Far from Adequate
US patients at high CV risk do not receive adequate evidence-based pharmacotherapy, according to large multisite cohort analysis.
After COVID-19, Risk Increases for Wide Range of Mental Health Disorders
Among persons who survived COVID-19, a new study found a 60% increased risk for any new mental health diagnosis during the year following infection.
Hypertension Toolkit for Primary Care Practice: A Heart Month Checklist
Recommendations on hypertension management from the US Surgeon General's office are summarized for at-a-glance American Heart Month reading.
2022 Opioid Prescribing Guideline Update Open for Public Comment, says CDC
The CDC is inviting public feedback on updated recommendations for opioid prescribing for the first time since the controversial 2016 iteration.
Diabetes Care & Education Specialists, ADA Update National Standards for Diabetes Self-management Education and Support
The 2022 DSMES National Standards update focuses on reducing administrative burden on educators and improving person-centered care for patients.
US States Ranked by Life Expectancy in National Vital Statistics Report
The 50 states and DC are ranked by longest and shortest life expectancy at birth and at age 65 years and by the difference in life expectancy between men and women.
FDA Approves Eversense E3 CGM System for Use up to 6 Months
The 180-day sensor life doubles the period of continuous use and cuts in half the number of CGM removals and reinsertions, without loss of accuracy.
Relapse After Smoking Cessation is High Among Stroke, TIA Survivors: New Findings
The 5-year cumulative relapse rate among early quitters was nearly 40% in a large international cohort of stroke patients, according to an abstract presented at ISC22.
Obesity Common Among Adults Aged <50 Years with Acute Ischemic Stroke, Study Finds
Nearly two-thirds of persons aged younger than 50 years who had an acute ischemic stroke had obesity in a study presented at the 2022 International Stroke Conference.
Prior Authorization Process Could Threaten Patient Outcomes: AMA Survey
Prior authorization-related delays in care have led to serious patient outcomes, including hospitalization, disability, even death, said one-third of physicians surveyed.
Risk for Diabetes in Older Women Reduced by 12% with 2000 Steps per Day: Study
Higher daily step counts by women aged ≥65 years was associated with reduced risk for incident diabetes, an effect that was modified by the level of stepping intensity.
Blood Glucose Levels in T2D: 42 Factors that Make A Difference
These 42 factors that affect blood glucose are listed in categories including food, activity, and biological influences. Perfect information to share with your patients with T2D.
Tirzepatide Found Safe, Effective as Add-on to Stable Basal Insulin in T2D Patients Not at Goal
Tirzepatide at 3 different doses significantly improved glycemic control and promoted weight loss when added to titrated insulin in patients with type 2 diabetes.
SGLT-2 Inhibitors and GLP-1 RAs May Reduce NAFLD Risk in T2D
Use of SGLT2 inhibitor and GLP-1 RA therapy in patients with type 2 diabetes appears to confer hepatic protection when compared with use of DPP-4 inhibitors.
Real Time CGM Improves A1c, Time in Range in T2D Patients on Less Intensive Treatment
Greatest improvements in A1c, %TIR, and other glycemic parameters were seen in patients treated with ≤1 medication, in another challenge to current payer restrictions.
What has COVID-19 Taught the US About Flu?
Vaccination against flu is the best protection from the infection according to 61% of US adults surveyed by NFID. How do the rest feel about the threat?
Call for a NAFLD Care Pathway in T2D in Primary Care
Integrating NAFLD as a diabetes complication to be addressed during routine cycles of care could reduce barriers to a NAFLD pathway in primary care, agreed focus group participants.
Your T2D Patient Needs Mealtime Insulin: Counsel on Options, then Move Ahead
NYU endocrinologist Brian Levy, MD, offers perspective on keeping the transition from basal insulin to multiple daily injections as simple as possible for patient and provider.
COVID-19 Hospitalization 23 Times Higher for Unvaccinated During Omicron Surge
The COVID-19 Omicron variant may cause milder disease than the Delta variant, but its rapid spread in Los Angeles County still singled out unvaccinated Angelinos.
Topline Phase 3 Data for NASH Candidate Resmetirom Set Promising Stage
Adverse events seen with resmetirom were similar across dose and placebo groups and there were "significant reductions" seen in liver fat, LDL-C, and ApoB.
Barriers to Intensifying Insulin in T2D Management: An Interview on Clinical Inertia
Type 2 diabetes patients-and their PCPs-may have trouble moving to basal + mealtime insulin from basal insulin alone. Endocrinologist Brian Levy, MD, offers insights.
Tezepelumab Reduces Exacerbations in Patients with Severe Asthma Regardless of Season
New data from the phase 3 NAVIGATOR trial demonstrate superior efficacy of tezepelumab to reduce asthma exacerbations in severe disease year round.
Omicron Subvariant BA.2: What We Know Now
Known as BA.2, the new Omicron subvariant is now circulating at low levels in the US. What can you tell your patients? Here's what we know, now.
COVID Sequelae and Primary Care: An Interview with Author Samoon Ahmad, MD
The psychiatrist-author of "Coping with COVID-19: The Mental, Medical, and Social Consequences of the Pandemic," talks frankly about the pandemic's long-term impact on American health.
FDA Approves Second COVID-19 Vaccine, Moderna's Spikevax
Acting FDA Commissioner Janet Woodcock, MD, hopes the approval will help motivate more Americans to get vaccinated.
Hospitalization for Hypertensive Crises Doubles in US While Overall Hypertension Control Improves
Hospitalization rates for men with hypertensive crisis were higher vs for women, but odds of death during hospitalization decreased for both sexes between 2004-2014.